Search for: "State v. Janssen" Results 161 - 180 of 239
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2011, 2:00 am by Marie Louise
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
11 Aug 2011, 7:58 am by info@thomasjhenrylaw.com
“Despite the narrow FDA-approved indications for Risperdal, Janssen developed and executed marketing and sales plans designed to promote Risperdal for uses that had not been established to be safe and/or effective and to minimize the many risks associated with Risperdal's use,” Commonwealth of Massachusetts v. [read post]
20 Jul 2011, 1:27 pm by Bexis
Janssen Pharmaceuticals, Inc., 2011 WL 2640801, slip op. [read post]
6 Jun 2011, 6:12 am by Brian A. Comer
J&J’s 4.95 percent bonds due in 2033 fell 1.36 percent to 102.3 cents on the dollar, according to Trace, the bond-price reporting system of the Financial Industry Regulatory Authority.The case is State of South Carolina v. [read post]
28 Apr 2011, 3:18 pm by Bexis
 At least the state of the art at the time of the plaintiff’s use applies – unknown and later discovered risks are irrelevant. [read post]
23 Mar 2011, 5:02 am by Brian A. Comer
“After the judge makes a determination as to damages, we will consider our options,” Panico said in his statement.The case is State of South Carolina v. [read post]
22 Mar 2011, 5:08 am by Brian A. Comer
Risperdal is different from other antipsychotic medicines and “doctors needed to know that,” he added.Jurors will begin deliberating the case tomorrow.The case is State of South Carolina v. [read post]
24 Feb 2011, 1:49 pm by Bexis
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
11 Jan 2011, 11:07 pm by Kelly
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post… [read post]
16 Dec 2010, 1:54 pm by Bexis
, 2010 WL 4870149, at *7 (quoting State Farm Florida Insurance Co. v. [read post]